Leflunomide: a drug with a potential beyond rheumatology

Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis

(2013) Katrina E. Donahue et al.   ANNALS OF INTERNAL MEDICINE

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis

(2009) T. Sawada et al.   RHEUMATOLOGY

Leflunomide Therapy for Polyomavirus-Induced Allograft Nephropathy: Efficient BK Virus Elimination Without Increased Risk of Rejection

(2009) S. Teschner et al.   TRANSPLANTATION PROCEEDINGS

Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial

(2008) V. Kliem et al.   AMERICAN JOURNAL OF TRANSPLANTATION

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Higher Levels of Leflunomide Are Associated with Hemolysis and Are not Superior to Lower Levels for BK Virus Clearance in Renal Transplant Patients

(2008) N. Leca et al.   Clinical Journal of the American Society of Nephrology